RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
1-Year Est. Return
12.81%
1 Year Est. Return
+12.81%
AUM
$791M
AUM Growth
-$79M
(-9.1%)
Holding
105
Top Buys
| 1 | +$15.7M | |
| 2 | +$12.6M | |
| 3 | +$12.1M | |
| 4 |
Cardinal Health
CAH
|
+$9.24M |
| 5 |
Neurocrine Biosciences
NBIX
|
+$7.47M |
Top Sells
| 1 | +$19.8M | |
| 2 | +$15.2M | |
| 3 | +$14.9M | |
| 4 |
UnitedHealth
UNH
|
+$14.7M |
| 5 |
McKesson
MCK
|
+$14.3M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Cooper Companies
COO
$14.5B
| $12.1M | 1.53% |
170,000
-66,000
|
|
||
27
Jazz Pharmaceuticals
JAZZ
$8.45B
| $11.6M | 1.46% |
109,030
-15,270
|
|
||
28
HCA Healthcare
HCA
$109B
| $11.4M | 1.44% |
29,778
+13,000
|
|
||
29
Procept Biorobotics
PRCT
$2.02B
| $10.9M | 1.38% |
190,000
-258,000
|
|
||
30
Cigna
CI
$82.5B
| $10.6M | 1.34% |
32,000
+3,800
|
|
||
31
Akero Therapeutics
AKRO
$4.32B
| $10.5M | 1.33% |
197,600
+105,100
|
|
||
|
VRNA
32
DELISTED
Verona Pharma
VRNA
| $10.1M | 1.27% |
106,500
+36,500
|
|
||
33
Natera
NTRA
$26.4B
| $9.71M | 1.23% |
57,500
-81,000
|
|
||
|
34
UnitedHealth
UNH
$331B
| $9.49M | 1.2% |
30,430
-47,000
|
|
||
35
Axsome Therapeutics
AXSM
$6.72B
| $9.48M | 1.2% |
90,800
-18,800
|
|
||
|
36
Cardinal Health
CAH
$38.9B
| $9.24M | 1.17% |
+55,000
|
|
||
37
BioMarin Pharmaceuticals
BMRN
$10.1B
| $8.23M | 1.04% |
149,650
-115,350
|
|
||
38
Abbott
ABT
$221B
| $7.96M | 1.01% |
58,500
+6,500
|
|
||
39
Ionis Pharmaceuticals
IONS
$11.6B
| $7.19M | 0.91% |
182,000
+101,000
|
|
||
40
Oscar Health
OSCR
$5.09B
| $6.69M | 0.85% |
312,092
-710,651
|
|
||
41
Molina Healthcare
MOH
$8.34B
| $6.61M | 0.84% |
22,200
-46,000
|
|
||
42
Merus
MRUS
$7.17B
| $6.1M | 0.77% |
116,000
+41,500
|
|
||
43
Alcon
ALC
$37.6B
| $5.99M | 0.76% |
+68,000
|
|
||
44
Dynavax Technologies
DVAX
$1.23B
| $5.6M | 0.71% |
565,000
|
|
||
45
Penumbra
PEN
$9.67B
| $5.52M | 0.7% |
21,500
+19,300
|
|
||
46
Centene
CNC
$16.3B
| $5.41M | 0.68% |
99,757
-26,243
|
|
||
47
Syndax Pharmaceuticals
SNDX
$1.13B
| $5.38M | 0.68% |
574,000
+141,000
|
|
||
48
Bruker
BRKR
$5.86B
| $5.08M | 0.64% |
123,315
+81,000
|
|
||
|
AVR
49
Anteris Technologies
AVR
$189M
| $4.74M | 0.6% |
1,250,763
-39,237
|
|
||
50
Astrana Health
ASTH
$1.53B
| $4.73M | 0.6% |
190,000
+40,000
|
|